Last reviewed · How we verify

NCT03611036: REHABSUP

Effect of Different Form of Upper Limb Muscles Training on Dyspnea in COPD

Completed NA Last updated 24 January 2025
What this trial tests

NA trial testing Strength training in COPD in 280 participants. Completed in 6 February 2023.

Timeline
21 November 2018
Primary endpoint
6 February 2023
6 February 2023

Quick facts

Lead sponsorUniversity Hospital, Brest
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment280
Start date21 November 2018
Primary completion6 February 2023
Estimated completion6 February 2023
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the effect of upper limbs strength training versus the effect of upper limbs endurance training, on dyspnea, in patients with COPD during a pulmonary rehabilitation program.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of different form of upper limb muscles training on dyspnea in chronic obstructive pulmonary disease: A study protocol.
    Beaumont M, Beaumont M, Péran L, Berriet AC, et al · · 2020 · cited 2× · PMID 32957334 · DOI 10.1097/md.0000000000022131
  2. Effect of different forms of upper limb muscle training on dyspnea in chronic obstructive pulmonary disease: a randomised controlled trial.
    Beaumont M, Péran L, Berriet AC, Ber CL, et al · · 2025 · PMID 40966966 · DOI 10.1016/j.rehab.2025.102021

Verify or expand the search:

Other trials of Strength training

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03611036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing